It is an unapproved investigational research chemical presented here for research and educational purposes only
The comprehensive testing approach supports research integrity by ensuring scientists working with 5 Amino 1MQ have access to verified high-quality compounds that meet their experimental requirements
Established Safety Profile Across all clinical studies, AOD-9604 demonstrated excellent safety and tolerability
The hypothesis is that AOD-9604's lipolytic activation releases free fatty acids into circulation, and fasted moderate-intensity cardio burns those mobilised fatty acids before insulin-driven re-esterification occurs
A comprehensive safety and tolerability study evaluated approximately 900 participants across six trials with the following protocols: Subcutaneous/Intravenous Protocols: Single doses ranging from 25 to 400 mcg/kg body weight were tested
Dont layer with Vitamin C, AHAs, BHAs, or retinoids in the same routine